AI's Impact on Healthcare: What Eli Lilly, Novo Nordisk, and Intuitive Surgical Can Teach Us

I recently stumbled across a fascinating trend: AI isn't reserved for the Silicon Valleys of the world anymore. It's making a substantial impact in industries we don't typically associate with high-tech innovation. Take healthcare, for example. Companies like Eli Lilly, Novo Nordisk, and Intuitive Surgical are using AI to cut costs and develop new products faster. But how, you ask?

The Deep Dive into AI and Drug Development

Let's start with Eli Lilly. They're not just dabbling in AI. they're going all in. In partnership with Nvidia, they're building what might be the most powerful supercomputer in the pharmaceutical industry. Why? Simple. Drug development is a time-consuming and expensive process, often costing $2.8 billion and taking over a decade. By integrating AI into the process, Eli Lilly hopes to cut the drug discovery phase by a year or two. While it doesn't sound like much, this reduction can lead to significant cost savings and faster time-to-market for essential medicines.

Novo Nordisk and Intuitive Surgical aren't lagging behind either. Novo Nordisk has been exploring AI for precision medicine, aiming to tailor treatments to individual patients. Meanwhile, Intuitive Surgical uses AI to improve the capabilities of its surgical robots, making operations less invasive and more efficient. This approach could potentially revolutionize patient care and operational efficiency in hospitals.

Broader Implications for the Market

So, what does this mean for the broader market? For starters, the integration of AI into healthcare could drastically bring down costs. If AI can make drug development cheaper, patients might see lower prices on essential medicines. Additionally, faster development times mean that life-saving drugs get to market quicker, potentially improving outcomes for patients waiting for new treatments.

But here's the catch. As AI becomes more ingrained in healthcare, companies that adapt quickly will see the most benefit. This creates a competitive space where those who can't keep up might fall behind. On the flip side, for investors, this opens up opportunities beyond traditional tech stocks. Healthcare firms embracing AI could become the next big winners in the market.

Your Move: What Should You Do?

So, what should you be doing with this information? If you're an investor, consider looking beyond the usual tech giants. The healthcare sector is ripe for disruption and those companies that are early adopters of AI are worth watching. Eli Lilly, Novo Nordisk, and Intuitive Surgical aren't just healthcare companies. they're becoming tech innovators in their own right.

But don't just take my word for it. The burden of proof sits with the team, not the community. Look at their track records. See if they're walking the walk, not just talking the talk. After all, skepticism isn't pessimism. It's due diligence.